Stocks' Recovery Attempt Fading - Investor's Business Daily (subscription)
April 19, 2007| Stocks' Recovery Attempt Fading Investor's Business Daily (subscription) - It reported sales of Remicade, for rheumatoid arthritis, and an allergy medication, Nasonex, helped push Q1 earnings up 50% to 36 cents a share. ... |
Nasdaq Logs Another Distribution Day - Investor's Business Daily (subscription)
April 19, 2007| Nasdaq Logs Another Distribution Day Investor's Business Daily (subscription) - It reported sales of Remicade, for rheumatoid arthritis, and an allergy medication, Nasonex, helped push Q1 earnings up 50% to 36 cents a share. ... |
Stocks Turn Higher In Midday Trade - Investor's Business Daily (subscription)
April 19, 2007| Stocks Turn Higher In Midday Trade Investor's Business Daily (subscription) - It reported sales of Remicade, for rheumatoid arthritis, and an allergy medication, Nasonex, helped push Q1 earnings up 50% to 36 cents a share. ... |
Madison County Bextra suit may be added to California MDL - St. Clair Record
April 19, 2007| Madison County Bextra suit may be added to California MDL St. Clair Record, IL - 16, 2001, for the relief of symptoms of osteoarthritis and adult rheumatoid arthritis. Shultz also claims jurisdiction lies in federal court because Fohne ... |
Stocks Slump On China News - Investor's Business Daily (subscription)
April 19, 2007| Stocks Slump On China News Investor's Business Daily (subscription) - It reported sales of Remicade, for rheumatoid arthritis, and an allergy medication, Nasonex, helped push Q1 earnings up 50% to 36 cents a share. ... |
Schering-Plough reports higher earnings, sales - MarketWatch
April 19, 2007| Schering-Plough reports higher earnings, sales MarketWatch - ... expected first-quarter earnings early Thursday, due largely to brisk sales of its rheumatoid arthritis drug Remicade and allergy medication Nasonex. ... |